Correlation Between Sinphar Pharmaceutical and G Shank

Can any of the company-specific risk be diversified away by investing in both Sinphar Pharmaceutical and G Shank at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinphar Pharmaceutical and G Shank into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sinphar Pharmaceutical Co and G Shank Enterprise Co, you can compare the effects of market volatilities on Sinphar Pharmaceutical and G Shank and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinphar Pharmaceutical with a short position of G Shank. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinphar Pharmaceutical and G Shank.

Diversification Opportunities for Sinphar Pharmaceutical and G Shank

0.68

Correlation Coefficient

Sinphar Pharmaceutical  G Shank

Poor diversification

The 3 months correlation between Sinphar and 2476 is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Sinphar Pharmaceutical Co and G Shank Enterprise Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on G Shank Enterprise and Sinphar Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinphar Pharmaceutical Co are associated (or correlated) with G Shank. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of G Shank Enterprise has no effect on the direction of Sinphar Pharmaceutical i.e., Sinphar Pharmaceutical and G Shank go up and down completely randomly.

Pair Corralation between Sinphar Pharmaceutical and G Shank

Assuming the 90 days trading horizon Sinphar Pharmaceutical Co is expected to under-perform the G Shank. But the stock apears to be less risky and, when comparing its historical volatility, Sinphar Pharmaceutical Co is 2.65 times less risky than G Shank. The stock trades about -0.21 of its potential returns per unit of risk. The G Shank Enterprise Co is currently generating about -0.07 of returns per unit of risk over similar time horizon. If you would invest  9,500  in G Shank Enterprise Co on September 25, 2024 and sell it today you would lose (970.00) from holding G Shank Enterprise Co or give up 10.21% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Sinphar Pharmaceutical Co  vs.  G Shank Enterprise Co

Sinphar Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sinphar Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

G Shank Enterprise

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days G Shank Enterprise Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with Sinphar Pharmaceutical and G Shank

The main advantage of trading using opposite Sinphar Pharmaceutical and G Shank positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinphar Pharmaceutical position performs unexpectedly, G Shank can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in G Shank will offset losses from the drop in G Shank's long position.

The idea behind Sinphar Pharmaceutical Co and G Shank Enterprise Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.